Sign in

CIK 0001490978

  • Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954284541
Phone
+1 503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,781,663
in 3 filings, $2.8M under 10b5-1 plans

Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-09 Lorton Kenneth Patrick EVP & Chief Technology Officer Grant or award +8,170 57,388
2023-02-09 Lorton Kenneth Patrick EVP & Chief Technology Officer Grant or award · Stock Option (right to buy) +49,000 49,000
2023-02-09 Herman Jenny SVP & Controller Grant or award +8,000 8,003
2023-02-09 Herman Jenny SVP & Controller Grant or award · Stock Option (right to buy) +13,000 13,000
2023-02-09 Farid Ramy President & CEO Grant or award · Stock Option (right to buy) +84,960 84,960
2023-02-09 Farid Ramy President & CEO Grant or award · Stock Option (right to buy) +65,525 65,525
2023-02-09 Akinsanya Karen President of R&D, Therapeutics Grant or award · Stock Option (right to buy) +63,270 63,270
2023-02-09 Abel Robert Lorne Grant or award +10,545 10,545
2023-02-09 Abel Robert Lorne Grant or award · Stock Option (right to buy) +63,270 63,270
2023-02-02 Tran Yvonne EVP & Chief Legal Officer Exercise or conversion +11,731 $2.92 $34K 16,862
2023-02-02 Tran Yvonne EVP & Chief Legal Officer Exercise or conversion +13,269 $3.07 $41K 30,131
2023-02-02 Tran Yvonne EVP & Chief Legal Officer Sale −25,000 $27.26 $681K 5,131
2023-02-02 Tran Yvonne EVP & Chief Legal Officer Exercise or conversion · Stock Option (right to buy) −11,731 $2.92 $34K 0
2023-02-02 Tran Yvonne EVP & Chief Legal Officer Exercise or conversion · Stock Option (right to buy) −13,269 $3.07 $41K 108
2023-01-04 Farid Ramy President & CEO Exercise or conversion +66,886 $1.20 $80K 251,318
2023-01-04 Farid Ramy President & CEO Sale −66,886 $18.28 $1.2M 184,432
2023-01-04 Farid Ramy President & CEO Exercise or conversion · Stock Option (right to buy) −66,886 0
2022-08-18 Porges Geoffrey Craig EVP & CFO Grant or award · Stock Option (right to buy) +180,000 180,000
2022-08-11 Thornberry Nancy Director Exercise or conversion +4,950 $11.52 $57K 4,950
2022-08-11 Thornberry Nancy Director Sale −4,950 $35.00 $173K 0

Page 12 of 60 · 1,192 trades